Immuneering (IMRX) Receivables - Net (2020 - 2023)

Immuneering's Receivables - Net history runs 4 years deep, the most recent figure standing at $1046.0 for Q1 2023.

• In Q1 2023, Receivables - Net fell 99.63% year-over-year to $1046.0; the TTM figure through Mar 2023 stood at $1046.0 (down 99.63% YoY), while the FY2022 annual figure was $12417.0, down 94.95% from the prior year.
• Receivables - Net was $1046.0 for Q1 2023 at Immuneering, down from $12417.0 in the prior quarter.
• In the past five years, Receivables - Net ranged from a high of $500110.0 in Q4 2020 to a low of $1046.0 in Q1 2023.
• Historically, Receivables - Net has averaged $250479.1 across 4 years, with a median of $246040.0 in 2021.
• The sharpest annual moves came in 2021 and 2023: Receivables - Net tumbled 50.8% in 2021, then sank 99.63% in 2023.
• A 4-year view of Receivables - Net shows it stood at $500110.0 in 2020, then sank by 50.8% to $246040.0 in 2021, then slumped by 94.95% to $12417.0 in 2022, then tumbled by 91.58% to $1046.0 in 2023.
• The last three Receivables - Net figures came in at $1046.0 (Q1 2023), $12417.0 (Q4 2022), and $70180.0 (Q3 2022), per Business Quant data.